Gene Query: MAPK8IP1

Dataset Description Geneva Score
Self-organization of polarized cerebellar plate neuroepithelium in three-dimensional culture of human pluripotent stem cells 73.14
Metabolic Reprogramming Associated with Aggressiveness Occurs in the G-CIMP-High Molecular Subtypes of IDH1mut Lower Grade Gliomas 31.9
RNA sequencing of BT142 and TS603 cell lines 31.9
A peninsular structure coordinates asynchronous differentiation with morphogenesis to generate pancreatic islets [bulk vs buds] 30.16
Rescue of Fragile X syndrome by DNA methylation editing of the FMR1 25.83
Rescue of Fragile X syndrome neurons by DNA methylation editing of the FMR1 gene [RNA-seq] 25.83
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 22.22
Genome-wide expression change by SHARPIN knockdown in MCF-7 cells 21.98
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 20.47
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 20.04
circRNA-sequencing 19.81
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 19.02
Comprehensive evaluation of differential gene expression analysis methods for RNA-seq data 18.81
ETV7 and interferon response 18.39
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 18.39
Genome-wide functional assessment of enhancer activities in the human genome 18.25
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 17.69
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 17.27
Risk SNPs mediated promoter-enhancer switching promotes prostate cancer progression through lncRNA PCAT19 (RNA-seq data sets) 17.27
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer 17.08
Modeling the ESR1 tyrosine 537 mutation with CRISPR-Cas9 for mechanistic studies and evaluation of therapeutic approaches for metastatic breast cancer [RNA-Seq] 17.08
Transcriptome analysis of small molecule-mediated astrocyte-to-neuron reprogramming 16.25
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells 15.96
JMJD3 and UTX Determine Fidelity and Lineage Specification of Human Neural Progenitor Cells [RNA-seq] 15.96
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 15.89
Genome-wide chromatin analysis of Ewing sarcoma 15.89
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 15.25
Characterization of sperm lncRNA and its differently expression in the sperm of asthenozoospermic patients 15.24
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma 15.18
Mastermind-like 3 controls proliferation and differentiation in neuroblastoma (RNA-seq) 15.18
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 14.68
A Brain Penetrant Mutant IDH1 Inhibitor Provides In Vivo Survival Benefit 14.68
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 14.45
Regionally specified human pluripotent stem cell-derived astrocytes 14.32
Universal alternative splicing of noncoding exons 13.42
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 13.39
Induction of human SST and PV neurons by expressing a single transcription factor LHX6 13.0
Serotonin-induced hyperactivity in SSRI-resistant major depressive disorder patient-derived neurons 12.95
Modeling human brain evolution using induced pluripotent stem cells: comparative analysis of neuronal development in humans and chimpanzees 12.87
Control of prostate tumour growth by the long non-coding RNA GHSROS (LNCaP) 12.73
High-Throughput Kinetic Analysis of Fractional Killing 12.62
Epigenetic mechanisms underlie the crosstalk between growth factors and a steroid hormone [HCT RNA-Seq] 12.4
Telomere-Dependent and Telomere-Independent Roles of RAP1 in Regulating Human Stem Cell Homeostasis 12.28
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 12.06
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 12.06
HNRNPL and its RNA Targets in Prostate Cancer 12.05
Regulartory effect of HNRNPL and LARP on RNA expression in LNCaP prostate cancer cells 12.05
Epigenomic landscape during organ formation in human early embryos 12.03
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 12.02
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 11.88
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 11.88
Gene expression profiling via RNA sequencing of patient brain tumors cultured in 3D bioengineered cultures 11.75
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 11.64
DNA damage signaling mediates the functional antagonism between replicative senescence and terminal muscle differentiation 11.63
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 11.59
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 11.31
RNA-seq analysis reveals profound changes in transcript profiles between siCon- and siH19-transfected EVT cells 11.02
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 11.0
Examining serotonergic neuron differentiation from human iPSCs 10.89
Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence 10.51
Novel mutations segregating with Complete Androgen Insensitivity Syndrome and their molecular characteristics. 10.32
FUS mutant human motoneurons transcriptome analysis reveals altered pathways and impairment of microRNA function 10.26
Interaction with WDR5 recruits MYC to a small cohort of genes required for tumor onset and maintenance 10.1
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 10.08
Repurposing of promoters and enhancers during mammalian evolution 10.04
Genome-wide Dose-dependent Inhibition of Histone Deacetylases Reveals Their Roles in Enhancer Remodeling and Suppression of Oncogenic Super-enhancers 10.03
Lysine benzoylation is a novel histone mark 9.99
Lysine benzoylation is a novel histone mark [RNA-seq] 9.99
EGFR Mutation Promotes Glioblastoma Through Epigenome and Transcription Factor Network Remodeling 9.98
Bioinformatics analysis of transcriptome related to blood stasis syndrome in diabetes mellitus patients 9.84
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 9.8
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 9.8
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 9.8
FOXP1 orchestration of ASD-relevant signaling pathways. 9.65
Transciptome profiling of NoDice and RNaseIII null cells prior to and after polyIC treatment 9.47
RNAseq of HEK293 cells after Chtop knockdown 9.36
Co-transcriptional loading of RNA export factors shapes the human transcriptome 9.36
Total RNA sequencing of APC mutant and wt colonic organoids 9.34
Analysis of the Clustered Protocadherin (cPcdh) Locus in Human Pluripotent Stem and Derived Cells [RNA-seq II our of II] 9.22
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 9.2
Paired Related Homeobox Protein 1 Regulates Quiescence in Human Oligodendrocyte Progenitors 9.18
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 9.17
Engineered human pluripotent stem cell-derived intestinal tissues with a functional enteric nervous system 9.11
Genome-wide transcriptome profiles in Control and Schizophrenia hiPSC-dervied NPC [RNA-seq] 9.04
Next-generation sequencing of control and schizophrenia hiPSC derived NPC 9.04
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 8.7
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 8.53
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived NPCs 8.44
HNF1A deficiency impairs β-cell fate, granule maturation and function 8.08
Robust generation of honemogeneous midbrain organoids with in vivo–like cellular composition facilitates neurotoxin-based Parkinson’s disease modeling 8.03
Enhancer divergence and cis-regulatory evolution in the human and chimpanzee neural crest 7.68
RNA sequencing for PDX1, NGN3 and MAFA transduced iPSCs cell 7.59
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 7.55
LNCaP treated with iBET 7.43
Tracking of dCas9-methyltransferase footprints 7.38
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 7.21
Retinoic acid suppresses MYB in adenoid cystic carcinoma 7.21
A specific missense mutation in GTF2I occurs at high frequency in thymic epithelial tumors 7.17
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 7.07
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 7.0
Valproic acid attenuates hyperglycemia induced complement and coagulation cascade gene expression 6.98
Prospective Isolation and Comparison of Human Germinal Matrix and Glioblastoma EGFR+ Populations with Stem Cell Properties 6.91
RNA sequencing for human induced pluripotent stem cell cardiomyocyte differentiation 6.86
The expression of genes encoding palmitoylated proteins in axonal and synaptic compartments is affected in CLN1/PPT1 transfected neuronal cells 6.8
GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells to Posterior Neural Progenitors 6.79
Real-time observation of light-controlled transcription in living cells 6.77
RNA-seq analysis of RALD iPSCs after in vitro differentiation 6.72
RNA-Seq analysis of neurons derived from induced pluripotent stem cells reprogrammed from dental pulp 6.62
Expression profiling and occupancy after knockdown or over-expression of HFN1A or HNF4G in prostate cancer cells 6.58
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 6.56
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 6.54
Total RNAseq of human putamen and caudate nucleus tissues in healthy control and Bipolar Disorder individuals 6.51
Generating Patterned Kidney Organoids for Studying Development and Diseases [bulk RNA-Seq] 6.49
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures 6.47
Repression of stress-induced LINE-1 expression protects cancer cell populations from lethal drug-exposures [RNA-Seq] 6.47
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 6.39
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 6.39
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 6.39
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 6.34
Dissecting the dynamics of signaling events in the BMP,WNT and NODAL cascade during self-organized fate patterning in human gastruloids 6.33
PRRX2 and HEY2 double knock-down facilitates ASCL1-induced neuron conversion in human dermal fibroblasts. 6.28
Leukodystrophy-associated POLR3A mutations down-regulate the RNA polymerase III transcript and important regulatory RNA BC200 6.18
The landscape of alternative splicing in aggressive prostate cancers 6.14
DUX4-induced dsRNA and MYC mRNA Stabilization Activate Apoptotic Pathways in Human Cell Models of Facioscapulohumeral Dystrophy 6.1
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 6.03
Entrectinib Resistance in a Neuroblastoma Xenograft Model 5.99
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 5.97
ADAR1 controls apoptosis of stressed cells by inhibiting Staufen-mediated mRNA decay 5.91
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 5.9
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 5.83
The conserved transcriptional landscapes in human spermatogenesis 5.82
Novel Targeting of Transcription and Metabolism in Glioblastoma 5.8
Gene expression analysis of human haploid cells (HAP1) depleted of SMARCB1 and SMARCA4 5.77
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 5.7
CHD7 is Suppressed in the Perinecrotic/Ischemic Microenvironment and is a Novel Regulator of Angiogenesis 5.67
Functional astrocytes differentiated from hiPSCs 5.62
Network-based, cross-cohort discovery of transcriptional mechanisms presiding over maintenance of high-risk neuroblastoma subtype state 5.61
ASCL1 mediates neuronal differentiation of primary GBM stem cell cultures upon Notch signalling blockade [RNA-seq] 5.53
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 5.51
Rna-seq transcriptome data for insulin-GFP+ cells differentiated from NEUROD1 knock out and NEUROD1+/+ control human embryonic stem cells. 5.51
NEUROD1 dependent gene regulation in murine pancreatic endocrine cells and human stem cell derived insulin producing cells 5.51
A prostate cancer chromatin interaction map 5.46
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 5.41
RNA-seq of shEZH2 cells 5.4
RNA-seq of SCLC PDX models treated with EP 5.39
Discovery of a Drug Candidate for GLIS3-Associated Diabetes 5.35
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 5.33
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 5.31
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 5.31
Effect of PBK knockdown on C4-2 cell transcriptome 5.28
An integrative analysis of non-coding regulatory DNA variations associated with autism 5.24
Paxillin regulates genomic networks in prostate cancer [C4-2] 5.22
Messenger RNA expression after silencing or inhibition of MEN1in MCF-7 breast cancer cells 5.21
Analysis of transcriptional regulation by Myt1 and Myt1l 5.13
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 5.06
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 5.06
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (LNCaP RNA-seq) 5.04
The m 6 A-methylase complex recruits TREX and regulates mRNA export. 4.93
Genomic profiling of human spermatogonial stem cells [BulkRNA-Seq] 4.91
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 4.9
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes [RNA-Seq] 4.9
Mapping cis-regulatory chromatin contacts in neural cells links neuropsychiatric disorder risk variants to target genes 4.9
PTEN suppresses neoplastic transformation of human neural stem cells by transcriptional repression of Pax7 4.9
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 4.9
Expression profiling by high throughput sequencing of tumors derived from human prostate epithelial cells transformed with the oncogenes N-Myc and myrAKT1. 4.88
MYCL and EP400 are required for Max and MCPyV mediated gene activation 4.86
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence 4.85
Large-Scale Atlas of Mutant IDH1-Dependent Chromatin State Reprogramming, Reversibility, and Persistence [RNA-seq] 4.85
The effect of insulin on mRNA transcription of human pluripotent stem cells 4.81
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 4.78
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 4.77
Restoration of Progranulin Expression Rescues Cortical Neuron Generation in Induced Pluripotent Stem Cell Model of Frontotemporal Dementia 4.77
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 4.75
Mechanosensitive ion channel regulates tissue stiffening to promote glioma aggression 4.74
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.73
Receptor tyrosine kinase signaling promotes post-embryonic morphogenesis and survival of glia and neural progenitor cells 4.73
Dissecting neural differentiation regulatory networks through epigenetic footprinting 4.72
Transcriptional effect of ETV1 knockdown in melanoma cells 4.7
Silencing SPIB in attached and floating state of H1703 lung cancer cells 4.66
The Unfolded Protein Response Regulator, ATF6, Promotes Mesodermal Differentiation 4.6
Histone deacetylase inhibition enhances antimicrobial peptide but not inflammatory cytokine expression upon bacterial challenge 4.59
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells [RNA-seq] 4.58
Next-generation sequencing reveals a novel role of lysine-specific demethylase 1 in adhesion of rhabdomyosarcoma cells 4.58
Parkinson’s Disease Genetic Risk in a Midbrain Neuronal Cell Line 4.47
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer 4.47
Transcriptional Targeting Of Oncogene Addiction In Medullary Thyroid Cancer [RNA-Seq] 4.47
DJ-1 is dispensable for human stem cell homeostasis 4.46
FGF2 regulation of gene expression in stable inducible Neurons 4.45
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 4.44
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 4.44
Lipid catabolism inhibition sensitizes prostate cancer cells to antiandrogen blockade 4.35
Chemical Modulation of Glycolysis Regulates the KEAP1-NRF2 Pathway Through a Metabolite-Induced Posttranslational Modification 4.31
Nucleotide excision repair capacity increases during differentiation of human embryonic carcinoma cells into neurons and muscle cells 4.29
Genetic disruption of COX-1 inhibits multiple oncogenic pathways 4.28
A novel CRISPR-engineered prostate cancer cell line defines the AR-V transcriptome and identifies PARP inhibitor sensitivities. 4.24
Identification of HOXB13 target genes responsive to BET inhibitors 4.23
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [ribosome profiling] 4.21
Zika virus directly infects human peripheral neurons and induces cell death 4.2
Treatment Paradigms for Retinal and Macular Diseases Using 3-D Retina Cultures Derived From Human Reporter Pluripotent Stem Cell Lines 4.18
Human iPSC-based Modeling of Late-Onset Disease using Progerin-induced Aging 4.17
Global analysis of ZNF217 chromatin occupancy in the breast cancer cell genome reveals an association with Eralpha 4.14
Transcriptome data from human endocrine cells recovered from mouse grafts with pre-engraftment controls 4.13
RNA-sequencing of Wnt-dependent and Wnt-independent of Glioblastoma stem cell cultures 4.07
Identification of global XBP1s target gene expression in human prostate cancer cells 4.06
Transcriptomic profiling of cleavage-resistant RIPK1 induced autoinflammation syndrome patients 4.05
Integrated analyses of early responses to radiation in glioblastoma identify new alterations in RNA processing and candidate targets to improve treatment outcomes 4.04
Transcriptomic and Epigenomic analysis of Huntington's disease and control patient iPSC-derived neural cells 4.04
mRNAseq of Huntington's disease and control patient iPSC-derived neural cells 4.04
Transcriptome profiling of microRNA-mediated neuronal reprogramming with REST repression at day 7 4.03
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 4.01
The SPOP-containing Complex Functions as an E3 Ligase for SETD2 to Regulate Gene-Specific H3K36me3-Coupled Alternative Splicing 4.0
RNA-seq analysis of control and Myc-induced U2OS cells 3.97
Quantitative comparison between cellular mRNAs and exosomal mRNAs in human iPSC-derived motor neurons 3.95
Dtx3L and Androgen Signaling in Prostate Cancer 3.93
Next Generation Sequencing Facilitates Comparisons of Control and Schizophrenia-Patient derived hiPSC-derived neurons 3.92
Transcriptional profile of CAOV2 primary and CAOV2 recurrent cells 3.9
Discovery of cis-spliced chimeric RNAs between adjacent genes in human prostate cells 3.88
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 3.84
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 3.81
Modeling Trilateral Retinoblastoma using Human Embryonic Stem Cells 3.76
A large panel of isogenic APP and PSEN1 mutant human iPSC neurons reveals shared endosomal abnormalities mediated by APP b-CTFs, not Ab [RNA-seq] 3.76
RNA-Seq Analysis in hES/ iPS cell-derived neuronal samples 3.75
Lipid degradation promotes prostate cancer cell survival 3.73
Expression data for hiPSC-derived RPE treated with 10mM Nicotinamide or vehicle 3.72
Global transcriptional analysis of human extended pluripotent stem cells, human primed pluripotent stem cells, mouse extended pluripotent stem cells, and mouse embryonic stem cells by RNA-seq 3.69
Global transcriptional analysis and genome-wide analysis of chromatin state in extended pluripotent stem cells, primed pluripotent stem cells, and naïve pluripotent stem cells 3.69
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 3.69
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 3.69
G9a-Mediated Methylation of ERα Links the PHF20/MOF Histone Acetyltransferase Complex to Hormonal Gene Expression 3.68
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 3.66
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 3.65
Regionally distinct astrocyte interferon signaling promotes blood-brain barrier integrity and limits immunopathology during neurotropic viral infection 3.65
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 3.63
LIN28A modulates splicing and gene expression programs in breast cancer cells 3.62
LIN28A modulates splicing and gene expression programs in breast cancer cells [RNA-Seq] 3.62
Expression profiles of the four human major ectodermal lineages 3.62
Transcriptome analysis of H9 hESC derived cerebral organoids 3.61
CUREfast: Accelerating research with families 3.6
Studying the selectivity of a small molecule Synucleozid on transcriptome 3.6
Role of FGFR1 in neuronal devlopment 3.58
Maturation of human iNSCs 3.58
LncRNA NONHSAT113026 represses renal cell carcinoma tumorigenesis through interacting with NF-κB/p50 and SLUG 3.52
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 3.5
The human blood-nerve barrier transcriptome 3.48
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 3.46
Adaptive chromatin remodeling in glioblastoma stem cell plasticity and drug tolerance 3.45
NR2F2 study 3.39
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 3.39
DIGIT regulates endoderm differentiation of human embryonic stem cells 3.39
Transcriptomes of iPSC-derived and post-mortum Hypothalamus Neurons from obese and control donors 3.36
RNA-seq Profiles in Transcription elongation factors are in vivo-specific cancer dependencies in glioma 3.34
Transcription elongation factors are in vivo-specific cancer dependencies in glioma 3.34
Pomalidomide inhibits PD-L1 induction to promote anti-tumor immunity 3.33
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  3.31
Transcriptional profiling of MCF7 cells treated with H3B05942, E2, or standard of care compounds 3.26
The Human Testis Cell Atlas via Single-cell RNA-seq (Healthy men scRNA-seq data set) 3.26
Synaptic dysfunction in human neurons with Autism associated deletions in PTCHD1-AS 3.26
Species-specific maturation profiles of human, chimpanzee and bonobo neural cells 3.25
Total RNA sequencing of WT intestinal orgaonids. 3.24
Differentiation enhances Zika virus infection in neuronal brain cells 3.22
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 3.19
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex (RNA-Seq I) 3.14
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 3.13
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 3.13
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 3.13
DART-seq: an antibody-free method for global m6A detection 3.09
Reversible LSD1 Inhibition with HCI-2509 induces the p53 gene expression signature in high-risk neuroblastoma cells 3.08
High-efficiency RNA-based reprogramming of human primary fibroblasts 3.08
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability [RNA-Seq] 3.05
Neuronal brain region-specific DNA methylation and chromatin accessibility are associated with neuropsychiatric trait heritability 3.05
N6-methyladenosine (m6A) profiling of EndoC-bH1 cell line and RNA seq of Mettl14 knockout mice beta cell 3.04
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 3.03
Hyper-excitability of Neurons generated from Patients with Bipolar Disorder 3.01
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock [RNA-Seq] 3.01
Targeting Glioblastoma Stem Cells through Disruption of the Circadian Clock 3.01
PT2385 HIF2A inhibitor treatment of patient derived orthotopic xenograft neuroblastoma cells in the presence or absence of hypoxia 3.0
The MEF2B Regulatory Network - RNA-seq data 3.0
The MEF2B Regulatory Network 3.0
EP400 is required for Max and MCPyV mediated gene activation 3.0
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium 2.99
Waterpipe Smoking Induces Epigenetic Changes in the Small Airway Epithelium [RNA-Seq] 2.99
Silencing p300 in MCF7 cells to study expression and alternative splicing 2.99
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 2.98
Glioblastoma stem cells infected by ZIKA virus 2.98
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 2.97
Modelling and rescuing neurodevelopmental defect of Down syndrome using induced pluripotent stem cells from monozygotic twins discordant for trisomy 21 [RNA-seq] 2.97
RNA-seq analysis of CRISPR/Cas9 generated human BMPR2 deficient endothelial cell lines harboring mutations characteristic for hereditary pulmonary hypertension (HPAH) 2.96
The transition from proliferation to quiescence in glioblastoma stem-like cells requires Ca2+ signaling and mitochondria remodeling 2.94
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 2.93
A Surveillance System of Active Enhancers by a RACK7-histone Demethylase Complex 2.9
Next Generation Sequencing Facilitates Quantitative Analysis of human patient derived primary Glioblastoma (GBM) cancer cell Transcriptomes 2.9
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 2.89
MCF-7 as a model for functional analysis of breast cancer risk variants 2.87
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 2.86
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 2.85
Endothelial Cells Control Pancreatic Cell Fate at Defined Stages through EGFL7 Signaling 2.84
RNAseq of cell lines with knocked in ESR1 mutations 2.79
MDM2 and MDM4 are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors 2.79
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 2.76
Generation of Brain Region-specific Organoids using a Miniaturized Spinning Bioreactor and Modelling ZIKV Exposure 2.74
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 2.73
RNA-seq of SOX5 overexpressing primary human neuronal progenitors 2.71
a-synuclein accumulation in an iPSC derived model of early onset sporadic Parkinson’s Disease reveals novel drug targets 2.68
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 2.68
Comprehensive Transcriptome Analysis of Cerebral Cavernous Malformation Across Multiple Species and Genotypes 2.67
Transcriptome analysis of human lung epithelial cells 2.63
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 2.63
Comprehensive analysis of microRNA expression in regionalized human neural progenitor cells reveals microRNA-10 as a caudalizing factor 2.62
Maturing an Enteric Nervous System in Human Intestinal Organoid-derived Tissue-Engineered Small Intestine 2.61
Evaluation of RNA amplification and RNA-Seq library preparation protocols for spermatozoa RNA profiling 2.61
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 2.59
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 2.58
Effect of REST on cancer invasiveness in MCF-7 and MDA-MB-231 cells using RNA-sequencing (RNA-seq) analysis . 2.57
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 2.53
Acquisition of a hybrid E/M state is essential for tumorigenicity of basal breast cancer cells 2.52
Single amino acid change underlies distinct roles of H2A.Z subtypes in human syndrome 2.52
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer [RNA-seq] 2.49
Clinical and genomic crosstalk between glucocorticoid receptor and estrogen receptor α in endometrial cancer 2.49
Isogenic patient-derived human iPSCs, wild-type or heterozygous for PIK3CA-E418K 2.48
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation 2.48
5hmC dynamically correlated with enhancer's activities during hES-to-Pancreatic endoderm cell differentiation (RNA-Seq) 2.48
Gene expression profiling of patient's DCIS-IDC tandem lesions by RNA sequencing analysis 2.44
Zika Virus Has Oncolytic Activity against Glioblastoma Stem Cells 2.44
Downregulation of DDX5/DDX17 and REST 2.4
Mutations in EBF3 disturb transcriptional profiles and cause intellectual disability, ataxia and facial dysmorphism 2.4
RNAseq Study in CC-671 Treated Cal-51 Cells 2.37
LEDGF and HDGF2, histone H3K36 methyl-binding proteins that assist RNA polymerase II transcription through nucleosomes 2.37
Survival of pancreatic cancer cells lacking KRAS function 2.37
Effect of estrogen (E2) treatment on the C4-12 relative to the MCF7 cells 2.36
Effect of disulfiram treatment on pediatric high grade glioma 2.34
FMR1 reactivating treatments in Fragile X iPSC-derived neural progenitors in-vitro and in-vivo 2.33
Differential responses of human fetal brain neural stem cells to Zika virus infection 2.32
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 2.31
Gene expression regulated by CSA and CSB in neuroblastoma cell line 2.31
Simultaneous detection and relative quantification of coding and non-coding RNA using a single sequencing reaction 2.31
Transcriptome analyses of iPSC-derived neural stem/progenitor cells and cerebral organoids from monozygotic twins discordant for schizoaffective bipolar disorder 2.31
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-seq C-terminal mutant] 2.29
RNA-sequencing WT vs SOCS3 knockout Glioblastoma stem-cells 2.26
RNA seq with AML (NB4) cells upon FTO inhibition 2.25
Single-Cell RNA Sequencing Reveals Metallothionein Heterogeneity during hESC Differentiation to Definitive Endoderm [RNA-Seq] 2.24
Transcriptomic analysis to underly the heterogeneity between 4 cellular models derived from patients diagnosed with pediatric high-grade gliomas under controlled atmosphere (modulation of oxygen level). 2.23
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 2.21
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 2.21
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 2.19
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 2.18
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 2.18
Reversing Abnormal Neural Development by Inhibiting OLIG2 in Down Syndrome Human iPSC Brain Organoids and Neuronal Mouse Chimeras 2.17
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations [RNA-Seq] 2.15
DDX3X regulation of global translation is impaired by medulloblastoma-associated mutations 2.15
Genome-wide identification of cancer-specific alternative splicing in circRNA 2.15
Transcriptomic and gene ontology profiling of the human corneal cell types 2.14
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.12
Transcriptional dependencies in diffuse intrinsic pontine glioma 2.04
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 2.03
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 2.0
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 1.93
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 1.93
Expression profile of HNF1A knockdown and overexpression in 22RV1 and LNCaP cells respectively 1.93
High-throughput sequencing of pluripotent cells 1.92
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 1.91
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 1.91
Analysis of human, chimpanzee, macaque and mouse tissue transcriptomes using Next Generation Sequencing 1.9
Effects of Spaceflight on Human Induced Pluripotent Stem Cell-Derived Cardiomyocyte Structure and Function 1.9
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 1.89
The age and genomic integrity of neurons after cortical stroke in humans 1.87
ELAVL2-regulated transcriptional networks in human neurons link atlernative splicing, autism and human neocortical evolution 1.84
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 1.83
RNA-seq data of small cell carcinoma of the bladder (SCCB) /urothelial carcinoma (Non-SCCB) clinical samples, and bladder-PARCB cell lines 1.82
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.82
Activation of a SOX2-dependent transcriptional regulatory circuit drives glioblastoma. 1.78
N6-methyladenosine Recruits HNRNPG for Alternative Splicing Regulation 1.76
RNA-seq of H1299 cells in which either PRKCI or SOX2 was silenced by validated lentiviral shRNA constructs 1.76
Non-coding and coding transcriptional profiles are significantly altered in pediatric Retinoblastoma tumors 1.76
RNA-seq of hiPSCs-derived NPCs from 3 pairs of dizygotic discordant twins for Congenital Zika syndrome 1.75
Generating Patterned Kidney Organoids for Studying Development and Diseases 1.74
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.68
Novel kinase fusion oncogenes in post-Chernobyl radiation-induced pediatric thyroid cancers 1.67
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [H1 RNA-seq] 1.67
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain 1.62
Deciphering H3K4me3 Broad Domains Associated With Gene Regulatory Networks and Conserved Epigenomic Landscapes in the Human Brain [RNA-Seq] 1.62
Gene expression changes in human melanoma cell lines compared to primary melanocytes 1.6
Genome-wide RNA-sequencing of human islets 48 hour after transduction with adenoviruses expressing either GFP (control), or histone chaperone ASF1B. 1.59
Systematic analysis of gene expression profiles controlled by hnRNP Q and hnRNP R, two closely related human heterogeneous nuclear ribonucleoproteins. 1.58
polyA RNA Sequencing Analysis of HTR-8/SVneo cells after lnc-SLC4A1-1 overexpression 1.58
CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary (I) 1.57
Efficient derivation of microglia-like cells from human pluripotent stem cells 1.54
P120-catenin dependent glioma-cell networks drive growth and diffuse brain infiltration 1.5
RNA-Seq Analysis in purified iPS cell-derived neuronal samples 1.5
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 1.49
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 1.46
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 1.46
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP [Ago2-miRNA-target mRNA complexes] 1.45
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 1.38
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration [RNA-seq2] 1.32
Activin/Smad2-induced H3K27me3 reduction is crucial to initiate mesendoderm differentiation of ES Cells 1.3
RNA editing in nascent RNA affects pre-mRNA splicing 1.29
Epigenomic plasticity enables human pancreatic alpha to beta cell reprogramming 1.28
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 1.27
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 1.27
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 1.26
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 1.25
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 1.25
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 1.25
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations 1.24
Mechanism suppressing H3K9 trimethylation in pluripotent stem cells and its demise by polyQ-expanded huntingtin mutations [RNA-seq] 1.24
Discovering human diabetes-risk gene function with genetics and physiological assays 1.24
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas 1.2
H3.3K27M cooperates with p53 loss and Pdgfra gain in mouse embryonic neural progenitor cells to induce invasive high-grade gliomas [Human RNA-Seq] 1.2
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 1.2
UV_24h_GRO-Seq 1.2
mRNA-Seq profiling SIX2+ and Foxd1+ cells in mouse embryonic and SIX2+ and SIX2-/MEIS1+ cells human fetal kidney 1.19
Low H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.17
Human optic chiasm from healthy controls and multiple sclerosis patients 1.13
Multiple sclerosis and EAE 1.13
DNMT1-associated long non-coding RNA regulate global gene expression and DNA methylation in colon cancer 1.09
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 1.08
Profiling gene expression changes in primary ovarian tumors compared to matched normal fallopian tubes 1.08
Inhibition of H3K4 demethylation induces autophagy in cancer cell lines 1.07
Comparative analysis of WT and ZEB1 KO cells in different stages during differentiation 1.05
p53 activity results in DNA replication fork processivity 1.05
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 1.03
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 1.03
PTHrP overexpression in MCF7 cells 1.02
Impact of DNA demethylation agents (5-azacytidine or vitamin C) on gene expression in glioblastoma HSR-GBM1 cells 1.01
Induced DNA demethylation, genome instability and transcription 1.01
Evaluation of the effectiveness of semen collection and sperm purification methods for spermatozoa transcript profiling 0.98
Human pluripotent stem cell-derived brain tumor model uncovered embryonic stem cell signature as a key driver in atypical teratoid/rhabdoid tumor (RNA-Seq) 0.98
Verification and rectification of cell type-specific splicing of a Seckel syndrome-associated ATR mutation using iPS cell model 0.97
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 0.95
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.93
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.93
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.91
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 0.91
EWS-Fli and LNC regulated genes in comparison to GFP samples 0.9
Aberrant expression profile of lncRNA and mRNA in dilated cardiomyopathy by RNA-sequence 0.89
Co-regulation of transcription by BRG1 and Brm, two mutually exclusive SWI/SNF ATPase subunits 0.89
Cooperative and Antagonistic Transcriptional Regulation by BRG/BRM [RNA-seq] 0.89
Finding missing proteins from epigenetically manipulated human cells 0.88
Identification of the RB loss-induced transcriptome and E2F1 cistrome in prostate cancer 0.87
Identification of the RB loss-induced transcriptome in prostate cancer [RNA] 0.87
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 0.85
Transcriptome analysis of human embryonic stem cells (hESCs) upon siRNA-mediated knockdown of hESC-essential genes 0.84
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 0.83
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.81
BioProject PRJNA381064: Convergent origination of a Drosophila-like dosage compensation mechanism in a reptile lineage (Gene expression profiling in several tetrapod species, bulk tissue RNA-seq) 0.77
RNA-seq and ChIP-seq analysis of BMI1 or RING1B-silenced prostate cancer cells C4-2 0.75
Gene expression profiles in HMC3 cells after exposure to ketamine or its active metabolites: 2R6R-HNK and 2S6S-HNK 0.72
miR-155 plays a crucial role in ALS and is an immune therapeutic target [RNA-Seq] 0.72
Targeting miR-155 restores abnormal microglia and attenuates disease in SOD1 mice 0.72
Transcriptomic analysis of the effect of histone H4 K31R mutation in U2OS cells 0.69
Noncoding regions are the main source of targetable tumor-specific antigens 0.68
Characterizing the Chemoresistant Ovarian Cancer Population using the Heterogeneous PDX 0.65
Transcriptome analysis of human cumulus cells reveals hypoxia as the main determinant of follicular senescence. 0.64
The flightless I protein is involved in the genome-wide mRNA post-transcriptional regulation in lung carcinoma cells 0.63
A runaway PRH/HHEX-Notch3 feedback loop drives cholangiocarcinoma (RNA-Seq) 0.63
Human islets of varying quality: the good, the (not so) bad and the ugly 0.63
T47D xenografts treated with various combinations of ER- and PR-targeting therapies 0.56
Comparison of small cell lung cancer PDX model FHSC04 for response to LSD1 inhibitor RG6016/ORY1001 0.55
Identification of microRNA-dependent gene regulatory networks driving human pancreatic endocrine cell differentiation [RNA-Seq III] 0.54
Gene expression analysis of breast cancer cell-lines 0.53
Gene expression and genome-wide location analysis of breast cancer cell-lines 0.53
Engineering Patient-Specific Tissue Implants 0.53
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.5
Transcriptomic analysis of human neural progenitor cells differentiation into astrocytes 0.49
Single cell RNA-seq resolves lineage-specific activation dynamics of human blood and tissue T cells 0.48
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.44
Integrated Multi-omic Analysis of Esthesioneuroblastomas Identifies Two Subgroups Linked to Cell Ontogeny 0.43
YAP and MRTF-A, transcriptional co-activators of RhoA- mediated gene expression, are critical for glioblastoma tumorigenicity 0.43
A single cell reference map for human blood and tissue T cell activation 0.42
Genome wide association study of bone size yields eleven loci that also affect height, bone density, osteoarthritis and fractures 0.42
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells [RNA-Seq] 0.41
Evaluation of the immunogenicity of live-attenuated influenza vaccines in nasal epithelial cells in primary differentiated human nasal epithelial cells 0.41
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. [RNA-seq] 0.4
Molecular Signature of CAID Syndrome: Noncanonical Roles of SGO1 in Regulation of TGF-β Signaling and Epigenomics. 0.4
Defining the Transcriptional Landscape during Cytomegalovirus Latency with Single-Cell RNA Sequencing 0.38
Subtle asymmetry of gene expression in embryonic and foetal human brains 0.37
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 0.37
Integration of ATAC-seq and RNA-seq Identifies Human Alpha Cell and Beta Cell Signature Genes 0.33
RNA-Seq in PWS iPSC-derived neurons 0.32
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 0.3
Nickel exposure induces persistent mesenchymal phenotype in human lung epithelial cells through epigenetic activation of ZEB1 0.29
Discovery of Drug Candidates that Inhibit and Eliminate Zika Virus Infection in Fetal and Adult Brain 0.29
RNA-seq in endometrial stromal tumors 0.28
Cell cycle positioning drives heterogeneity within the pluripotent stem cell compartment 0.26
Paclitaxel plus Cirmtuzumab Achieves Greater Clearance of Patient-derived Xenografts By Targeting ROR1+ Breast Cancer Stem Cells 0.25
Functional Haploid Human Oocytes Generated from Polar Body Genomes 0.24
Functional Haploid Human Oocytes Generated from Polar Body Genomes (RNA-Seq) 0.24
Transcriptome-wide discovery of microRNA binding sites in human brain by Ago2 HITS-CLIP 0.21
Myc activation coordinates gene transcription and protein translation responses 0.19
Gene expression profiles of active and restricted R/G-HIV+ primary human fetal astrocytes 0.14
N6-methyladenine DNA Modification in Glioblastoma 0.12
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 0.12
Transcriptome analysis of PC9 cells with gefitinib or/and hypoxia treatment and comparison with gefitinib resistant PC9 cells and ALDH positive PC9 cells 0.11
Gene expression analysis of C4-2 cells treated with ACLY inhibitor and Enzalutamide 0.1
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.1
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 0.07
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 0.07
SOX10 Single Transcription Factor Based Fast and Efficient Generation of Oligodendrocytes from Human Pluripotent Stem Cells 0.07
The Human Testis Cell Atlas via Single-cell RNA-seq 0.03
Generation of low passage high grade serous ovarian cancer cell lines from primary tumors 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation